XOMA Stock (NASDAQ: XOMA) stock price, news, charts, stock research, profile.
Open | $25.550 |
Close | - |
Volume / Avg. | 1.267K / 18.920K |
Day Range | 25.200 - 26.750 |
52 Wk Range | 13.480 - 27.000 |
Market Cap | $301.571M |
P/E Ratio | - |
Dividend Yield | 8.410% |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 3.45% |
Days to Cover | 15.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of XOMA (NASDAQ: XOMA) through any online brokerage.
Other companies in XOMA’s space includes: Renovaro (NASDAQ:RENB), Inozyme Pharma (NASDAQ:INZY), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT) and Monte Rosa Therapeutics (NASDAQ:GLUE).
The latest price target for XOMA (NASDAQ: XOMA) was reported by HC Wainwright & Co. on Thursday, April 25, 2024. The analyst firm set a price target for 74.00 expecting XOMA to rise to within 12 months (a possible 185.50% upside). 8 analyst firms have reported ratings in the last year.
The stock price for XOMA (NASDAQ: XOMA) is $25.9193 last updated Today at April 25, 2024 at 10:59 AM EDT.
There are no upcoming dividends for XOMA.
XOMA’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for XOMA.
XOMA is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.